scispace - formally typeset
J

Jane W. Newburger

Researcher at Boston Children's Hospital

Publications -  582
Citations -  64913

Jane W. Newburger is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Kawasaki disease & Medicine. The author has an hindex of 114, co-authored 515 publications receiving 55331 citations. Previous affiliations of Jane W. Newburger include Brigham and Women's Hospital & University of Texas at Austin.

Papers
More filters
Journal ArticleDOI

Relation of Seizures After Cardiac Surgery in Early Infancy to Neurodevelopmental Outcome

TL;DR: In infants undergoing the arterial switch operation for correction of D-transposition of the great arteries, transient postoperative clinical and EEG seizures were associated with worse neurodevelopmental outcomes at ages 1 and 2 1/2 years as well as neurological and MRI abnormalities at 1 year of age.
Journal ArticleDOI

Unique features of infective endocarditis in childhood

TL;DR: This paper focuses on the features that are particularly relevant to infants and children, including important issues for the primary care physician, as well as approaches to the prevention of endocarditis, which have been recently modified.
Journal ArticleDOI

Cardiovascular health supervision for individuals affected by duchenne or becker muscular dystrophy

TL;DR: Recommendations for optimal cardiovascular evaluation are provided to health care specialists caring for individuals in whom the diagnosis of Duchenne or Becker muscular dystrophy has been confirmed.
Journal ArticleDOI

Executive Function in Children and Adolescents with Critical Cyanotic Congenital Heart Disease

TL;DR: With increased understanding of the cognitive and self-regulatory vulnerabilities experienced by children and adolescents with CHD, it may be possible to identify risks early and provide individualized supports to promote optimal neurodevelopment.
Journal ArticleDOI

Gamma globulin re-treatment in Kawasaki disease.

TL;DR: It is concluded that intravenous gamma-globulin re-treatment of Kawasaki disease appears to be safe and may improve the clinical course.